INVO Bioscience Acquires NAYA Biosciences; Combined Company to Operate as NAYA Biosciences
October 14, 2024
INVO Bioscience has completed a reverse-triangular merger to acquire 100% of NAYA Biosciences, and the combined company will operate as NAYA Biosciences (NASDAQ: NAYA). The combined business will continue INVO's revenue-generating fertility operations while adding NAYA's clinical-stage oncology and autoimmune therapeutics pipeline and updating management and board composition.
- Buyers
- INVO Bioscience
- Targets
- NAYA Biosciences
- Sellers
- Security holders of NAYA Biosciences
- Industry
- Biotechnology
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
INVO Bioscience Acquires Wisconsin Fertility Institute
March 20, 2023
Healthcare Services
INVO Bioscience, Inc. (Nasdaq: INVO) has signed binding agreements to acquire Wisconsin Fertility Institute, a Madison-area fertility clinic that generated approximately $5.5 million in trailing 12-month revenue. The purchase price is $10.0 million payable over three years, and the clinic will become a wholly owned subsidiary to expand INVO's clinic footprint and support adoption of its INVOcell technology.
-
EPAM Systems Acquires NAYA Technologies (and US subsidiary NAYA Tech)
November 5, 2019
IT Services
EPAM Systems has acquired NAYA Technologies, an Israel-headquartered consultancy, and its US subsidiary NAYA Tech (San Jose, CA) to strengthen EPAM's cloud migration, data management and database migration capabilities, including the migVisor automated migration assessment tool. The acquisition augments EPAM's technology consulting practice and accelerates its ability to deliver end-to-end cloud and data services to enterprise clients.
-
Asahi Kasei Medical Acquires Bionova Scientific
April 14, 2022
Biotechnology
Asahi Kasei Medical agreed to wholly acquire Bionova Scientific, a Fremont, California-based biopharmaceutical CDMO that provides process development and GMP-compliant manufacturing services for next-generation antibody drugs. The acquisition, executed through a U.S. subsidiary, expands Asahi Kasei Medical's bioprocess and CDMO capabilities to better serve biologics developers and accelerate growth of its bioprocess business; closing is subject to regulatory clearances.
-
USANA Health Sciences Acquires 78.8% Stake in Hiya Health
December 23, 2024
Consumer Products
USANA Health Sciences acquired a 78.8% controlling stake in Hiya Health Products, LLC for approximately $205 million in cash, closing December 23, 2024. The acquisition expands USANA's direct-to-consumer presence in the children's health and wellness market and is expected to be accretive to USANA's 2025 adjusted EBITDA.
-
Nuvei Acquires Paya for $1.3 Billion
January 9, 2023
Payments & Fintech
Nuvei Corporation agreed to acquire Paya Holdings Inc. in an all-cash transaction valued at approximately $1.3 billion (USD $9.75 per share). The deal combines Nuvei's global payment platform with Paya's U.S. integrated-payments and ISV capabilities to accelerate growth in eCommerce, integrated payments and B2B end markets.
-
Bionano Genomics Acquires BioDiscovery
October 12, 2021
Software
Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.